Biotechnology and pharmaceutical industry in the next ten years
Article PDF
References
Avery, O.T. et al. 1944. J.Exp. Med. 79: 137–158.
Watson, J.D. and Crick, F.H.C. 1953. Nature 171: 737–738.
Drews, J. 1992. Scientific Paradigms in Medicine. Editiones Roche, Basel.
Cohen, S.N. et al. 1973. Proc. Natl. Acad. Sci. USA 70: 3240–3244.
Drews, J. 1989. Drug News and Perspectives 2: 453–460.
Jones, P.T., et al. 1986. Nature 321: 522–525. Reichmann, L., et al. 1988. Nature 332: 323–329.
Daniel, M.D. et al. 1992. Science 258: 1938–1941.
Lesslauer, W. et al. 1991. Eur. J. Immunol. 21: 2883–2886.
Prous, J.R. 1991. Drug News and Perspectives 4: 96–109.
Burrill, S. and Lee, K.B. Jr. 1992. Biotech 1993. Accelerating Commercialization. Ernst and Young, San Francisco.
Drews, J. 1990. Pharm Weekbl Sci. 12: 6–10.
Popper, K. 1964. The Poverty of Historicism. Newark and Evanston (Harper Torchbook), New York.
Author information
Author notes
Jürgen Drews, M.D.,is president for international research and development at Hoffmann-La Roche. He can be reached through Hoffmann-La Roche, 340 Kingsland St., Nutley, New Jersey 07110-1199.
- Jürgen Drews
Rights and permissions
About this article
Cite this article
Drews, J. Into the 21st Century. Nat Biotechnol 11, S16–S20 (1993). https://doi.org/10.1038/nbt0393-S16
Issue date:
DOI: https://doi.org/10.1038/nbt0393-S16
This article is cited by
-
Blood Brothers
Nature Biotechnology (1993)
